Results 21 to 30 of about 25,460 (223)
The use of botulinum toxin for the treatment of overactive bladder syndrome
Indian Journal of Urology, 2013 Over the last 50 years, botulinum toxin has been transformed from a cause of life-threatening disease to an effective medical therapy. It has been used in a variety of specialties for different indications, significantly improving patient quality of life.
Bogdan Orasanu, Sangeeta T Mahajan
doaj +1 more source
Impairment of AMPK-α2 augments detrusor contractions in bladder ischemia [PDF]
Investigative and Clinical Urology, 2021 Purpose: Ischemia disrupts cellular energy homeostasis. Adenosine monophosphate-activated protein kinase alpha-2 (AMPK-α2) is a subunit of AMPK that senses cellular energy deprivation and signals metabolic stress.
Jing-Hua Yang +3 more
doaj +1 more source
Current Therapeutic Research, 2022 : Background: Overactive bladder (OAB) is a common clinical condition for which current drug treatment comprises drugs blocking the cholinergic nerve supply, or augmenting the adrenergic nerve supply, to the detrusor muscle of the urinary bladder ...
Silvia Joseph, MBBS +2 more
doaj +1 more source
Taiwanese Journal of Obstetrics & Gynecology, 2012 Objective: The objective of this study was to demonstrate the diversity of urodynamic findings and temporal effects on bladder dysfunction in diabetes as well as to evaluate the predisposing factors that attenuate the storage and voiding function of ...
Tzu-Li Lin +4 more
doaj +1 more source
Solifenacin-induced acute psychosis: a case report
General Psychiatry, 2021 Solifenacin is a muscarinic receptor antagonist that has been used to treat overactive bladder since 2004. It has a great affinity for the detrusor M3 receptor, which must be stimulated for bladder muscle contraction, and demonstrates the most selective ...
Betul Kirsavoglu +2 more
doaj +1 more source
Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms [PDF]
International Neurourology Journal, 2011 To evaluate the relationship between urodynamic detrusor overactivity (DO) and overactive bladder (OAB) symptoms in men and women.We reviewed the records of adult males and females who attended a tertiary referral center for urodynamic evaluation of OAB syndrome symptoms with the presence or absence of DO.
Mohammed A. Al-Ghazo +5 more
openaire +3 more sources
Pathophysiological Mechanisms Involved in Overactive Bladder/Detrusor Overactivity [PDF]
, 2023 Purpose of Review: To examine the latest published findings on the pathophysiological mechanisms involved in the development of overactive bladder (OAB) and detrusor overactivity (DO), and to identify common pathways linked to the risk factors associated
Russ Chess-Williams +3 more
core +1 more source
CORRELATION BETWEEN OVERACTIVE BLADDER (OAB) AND QUALITY OF LIFE (QoL).
Urogynaecologia International Journal, 2010 The primary symptoms of overactive bladder (OAB) include urinary urgency and frequency, with or without urge incontinence. OAB is urodynamically characterised by involuntary contractions of the detrusor muscles of the bladder.
V. Leanza +3 more
doaj +1 more source
Botulinum toxin A for the Treatment of Overactive Bladder
Toxins, 2016 The standard treatment for overactive bladder starts with patient education and behavior therapies, followed by antimuscarinic agents. For patients with urgency urinary incontinence refractory to antimuscarinic therapy, currently both American Urological
Po-Fan Hsieh +4 more
doaj +1 more source
Frontiers in Pharmacology, 2020 IntroductionLower urinary tract symptoms (LUTS) due to overactive bladder (OAB) are caused by spontaneous detrusor contractions. Medical treatment with muscarinic receptor antagonists or β3-adrenoceptor agonists aims to inhibit detrusor contractions, but
Bingsheng Li +12 more
doaj +1 more source